Varex Imaging Corp
For the period ended Mar 29, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 29, 2024 · Filed May 2, 2024
VREX$18.450.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders' Equity
| Three Months Ended March 29, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Retained Earnings · Total Varex Equity · Noncontrolling Interests · Total Stockholders' Equity | ||||||||
| (In millions) · Shares · Amount | ||||||||
| December 29, 2023 | 40.6 | $0.4 | $453.2 | $(2.2) | $117.5 | $568.9 | $14.1 | $583.0 |
| Net income | — | — | — | — | 1.4 | 1.4 | 0.2 | 1.6 |
| Common stock issued upon vesting of restricted shares | 0.1 | — | — | — | — | — | — | — |
| Shares withheld on vesting of restricted stock | — | — | (0.8) | — | — | (0.8) | — | (0.8) |
| Common stock issued under employee stock purchase plan | 0.2 | — | 2.0 | — | — | 2.0 | — | 2.0 |
| Share-based compensation | — | — | 4.1 | — | — | 4.1 | — | 4.1 |
| Foreign currency translation adjustments | — | — | — | 0.5 | — | 0.5 | — | 0.5 |
| Other | — | — | (0.1) | — | 0.1 | — | (0.2) | (0.2) |
| March 29, 2024 | 40.9 | $0.4 | $458.4 | $(1.7) | $119.0 | $576.1 | $14.1 | $590.2 |
| Three Months Ended March 31, 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Income · Retained Earnings · Total Varex Equity · Noncontrolling Interests · Total Stockholders' Equity | ||||||||
| (In millions) · Shares · Amount | ||||||||
| December 30, 2022 | 40.1 | $0.4 | $437.9 | $0.1 | $73.3 | $511.7 | $13.3 | $525.0 |
| Net income | — | — | — | — | 4.1 | 4.1 | 0.2 | 4.3 |
| Common stock issued upon vesting of restricted shares | 0.2 | — | — | — | — | — | — | — |
| Shares withheld on vesting of restricted stock | (0.1) | — | (1.4) | — | — | (1.4) | — | (1.4) |
| Common stock issued under employee stock purchase plan | 0.1 | — | 2.0 | — | — | 2.0 | — | 2.0 |
| Share-based compensation | — | — | 3.3 | — | — | 3.3 | — | 3.3 |
| Unrealized gain on change in fair value of available-for-sale securities | — | — | — | 0.1 | — | 0.1 | — | 0.1 |
| Other | 0.1 | — | (0.2) | — | — | (0.2) | (0.2) | (0.4) |
| March 31, 2023 | 40.4 | $0.4 | $441.6 | $0.2 | $77.4 | $519.6 | $13.3 | $532.9 |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
| Six Months Ended March 29, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Retained Earnings · Total Varex Equity · Noncontrolling Interests · Total Stockholders' Equity | ||||||||
| (In millions) · Shares · Amount | ||||||||
| September 29, 2023 | 40.5 | $0.4 | $450.4 | $(1.2) | $118.1 | $567.7 | $13.3 | $581.0 |
| Net income | — | — | — | — | 0.9 | 0.9 | 0.3 | 1.2 |
| Common stock issued upon vesting of restricted shares | 0.3 | — | — | — | — | — | — | — |
| Shares withheld on vesting of restricted stock | (0.1) | — | (1.8) | — | — | (1.8) | — | (1.8) |
| Common stock issued under employee stock purchase plan | 0.2 | — | 2.0 | — | — | 2.0 | — | 2.0 |
| Share-based compensation | — | — | 7.8 | — | — | 7.8 | — | 7.8 |
| Foreign currency translation adjustments | — | — | — | (0.5) | — | (0.5) | — | (0.5) |
| Business acquisitions | — | — | — | — | — | — | 0.7 | 0.7 |
| Other | — | — | — | — | — | — | (0.2) | (0.2) |
| March 29, 2024 | 40.9 | $0.4 | $458.4 | $(1.7) | $119.0 | $576.1 | $14.1 | $590.2 |
| Six Months Ended March 31, 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Income · Retained Earnings · Total Varex Equity · Noncontrolling Interests · Total Stockholders' Equity | ||||||||
| (In millions) · Shares · Amount | ||||||||
| September 30, 2022 | 40.1 | $0.4 | $469.1 | $0.1 | $63.8 | $533.4 | $13.3 | $546.7 |
| Net income | — | — | — | — | 7.2 | 7.2 | 0.3 | 7.5 |
| Cumulative effect of accounting change | — | — | (34.6) | — | 6.5 | (28.1) | — | (28.1) |
| Common stock issued upon vesting of restricted shares | 0.2 | — | — | — | — | — | — | — |
| Shares withheld on vesting of restricted stock | (0.1) | — | (1.4) | — | — | (1.4) | — | (1.4) |
| Common stock issued under employee stock purchase plan | 0.1 | — | 2.0 | — | — | 2.0 | — | 2.0 |
| Share-based compensation | — | — | 6.6 | — | — | 6.6 | — | 6.6 |
| Unrealized gain on change in fair value of available-for-sale securities | — | — | — | 0.1 | — | 0.1 | — | 0.1 |
| Other | 0.1 | — | (0.1) | — | (0.1) | (0.2) | (0.3) | (0.5) |
| March 31, 2023 | 40.4 | $0.4 | $441.6 | $0.2 | $77.4 | $519.6 | $13.3 | $532.9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.